Switch theme
Sign up to access all valuation multiples
Farmacias Benavides SAB de CV is a drug store chain in Mexico. The company offers prescription and over-the-counter medications.
1963
9.3K+
Last FY Revenue $927M
Last FY EBITDA $98.8M
$695M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Farmacias Benavides achieved revenue of $927M and an EBITDA of $98.8M.
Farmacias Benavides expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Farmacias Benavides valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $927M | XXX | XXX | XXX |
| Gross Profit | XXX | $285M | XXX | XXX | XXX |
| Gross Margin | XXX | 31% | XXX | XXX | XXX |
| EBITDA | XXX | $98.8M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 11% | XXX | XXX | XXX |
| EBIT | XXX | $46.1M | XXX | XXX | XXX |
| EBIT Margin | XXX | 5% | XXX | XXX | XXX |
| Net Profit | XXX | $15.2M | XXX | XXX | XXX |
| Net Margin | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | $15.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Farmacias Benavides's stock price is MXN 25 (or $1).
Farmacias Benavides has current market cap of MXN 10.2B (or $550M), and EV of MXN 12.9B (or $695M).
See Farmacias Benavides trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $695M | $550M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Farmacias Benavides has market cap of $550M and EV of $695M.
Farmacias Benavides's trades at 0.7x EV/Revenue multiple, and 7.0x EV/EBITDA.
Equity research analysts estimate Farmacias Benavides's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Farmacias Benavides's P/E ratio is not available.
See valuation multiples for Farmacias Benavides and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $550M | XXX | $550M | XXX | XXX | XXX |
| EV (current) | $695M | XXX | $695M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 7.0x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 15.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 36.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 19.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialFarmacias Benavides's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $26K for the same period.
Farmacias Benavides's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Farmacias Benavides's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Farmacias Benavides and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $26K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Profarma Distribuidora | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Dimed Distribuidora | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Farmacias Benavides acquired XXX companies to date.
Last acquisition by Farmacias Benavides was XXXXXXXX, XXXXX XXXXX XXXXXX . Farmacias Benavides acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Farmacias Benavides founded? | Farmacias Benavides was founded in 1963. |
| Where is Farmacias Benavides headquartered? | Farmacias Benavides is headquartered in Mexico. |
| How many employees does Farmacias Benavides have? | As of today, Farmacias Benavides has 9.3K+ employees. |
| Is Farmacias Benavides publicy listed? | Yes, Farmacias Benavides is a public company listed on MEX. |
| What is the stock symbol of Farmacias Benavides? | Farmacias Benavides trades under BEVIDESB ticker. |
| When did Farmacias Benavides go public? | Farmacias Benavides went public in 1993. |
| Who are competitors of Farmacias Benavides? | Similar companies to Farmacias Benavides include e.g. MedPlus India, SC Ropharma, Profarma Distribuidora, Pague Menos. |
| What is the current market cap of Farmacias Benavides? | Farmacias Benavides's current market cap is $550M |
| Is Farmacias Benavides profitable? | Yes, Farmacias Benavides is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
